Skip to content

Protea Biosciences Group, Inc.: 10-Q filed 2013-08-09

What Protea Biosciences Group, Inc. reported in its quarterly report filed 2013-08-09 (fiscal Q2 2013): 30 published measures, 100 facts as tagged in accession 0001144204-13-044474.

This filing

Form
10-Q (quarterly report)
Filed
2013-08-09
Fiscal period
fiscal Q2 2013
Accession
0001144204-13-044474 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Protea Biosciences Group, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-06-303,817,823USD
At 2012-12-314,212,031USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-06-30-8,329,985USD
At 2012-12-31-7,903,831USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-06-30308,632USD
At 2012-12-3127,604USD
At 2012-06-30467,139USD
At 2011-12-31505,277USD
At 2001-07-120USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-2,756,132USD91
2013-01-01 to 2013-06-30-5,361,959USD181
2001-07-13 to 2013-06-30-52,336,637USD4371
2012-04-01 to 2012-06-30-2,595,874USD91
2012-01-01 to 2012-06-30-5,527,128USD182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-06-30-4,619,907USD181
2001-07-13 to 2013-06-30-42,215,376USD4371
2012-01-01 to 2012-06-30-4,170,417USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-06-305,096,306USD181
2001-07-13 to 2013-06-3047,169,806USD4371
2012-01-01 to 2012-06-304,496,069USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-06-30-196,061USD181
2001-07-13 to 2013-06-30-4,640,085USD4371
2012-01-01 to 2012-06-30-341,710USD182

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2013-04-01 to 2013-06-3040,866,191shares91
2013-01-01 to 2013-06-3037,709,434shares181
2001-07-13 to 2013-06-3011,935,002shares4371
2012-04-01 to 2012-06-3028,084,109shares91
2012-01-01 to 2012-06-3027,720,180shares182

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-04-01 to 2013-06-300USD91
2013-01-01 to 2013-06-300USD181
2001-07-13 to 2013-06-300USD4371
2012-04-01 to 2012-06-300USD91
2012-01-01 to 2012-06-300USD182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-06-302,558,332USD
At 2012-12-312,790,464USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-06-30154,340USD181
2012-01-01 to 2012-06-30173,181USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-2,590,171USD91
2013-01-01 to 2013-06-30-5,019,792USD181
2001-07-13 to 2013-06-30-49,996,697USD4371
2012-04-01 to 2012-06-30-2,446,450USD91
2012-01-01 to 2012-06-30-5,294,640USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-06-301,237,198USD
At 2012-12-311,399,012USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-04-01 to 2013-06-30174,563USD91
2013-01-01 to 2013-06-30332,818USD181
2001-07-13 to 2013-06-302,363,272USD4371
2012-04-01 to 2012-06-30143,144USD91
2012-01-01 to 2012-06-30228,688USD182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-06-3010,332,783USD
At 2012-12-3110,032,836USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-06-30228,439USD
At 2012-12-31127,721USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-06-30607,632USD
At 2012-12-31905,186USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2013-04-01 to 2013-06-302,023,630USD91
2013-01-01 to 2013-06-304,071,263USD181
2001-07-13 to 2013-06-3026,779,224USD4371
2012-04-01 to 2012-06-301,813,395USD91
2012-01-01 to 2012-06-303,697,320USD182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-04-01 to 2013-06-30844,532USD91
2013-01-01 to 2013-06-301,708,135USD181
2001-07-13 to 2013-06-3027,469,934USD4371
2012-04-01 to 2012-06-30857,018USD91
2012-01-01 to 2012-06-302,000,776USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-06-3042,196,147shares
At 2012-12-3131,879,247shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2013-06-30-5,713USD
At 2012-12-31-6,403USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2013-06-303,109,262USD
At 2012-12-313,457,515USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-06-3022,293USD
At 2012-12-3122,555USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-2,756,132USD91
2013-01-01 to 2013-06-30-5,361,959USD181
2001-07-13 to 2013-06-30-52,336,637USD4371
2012-04-01 to 2012-06-30-2,595,874USD91
2012-01-01 to 2012-06-30-5,527,128USD182

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-2,743,922USD91
2013-01-01 to 2013-06-30-5,361,269USD181
2001-07-13 to 2013-06-30-52,342,350USD4371
2012-04-01 to 2012-06-30-2,583,608USD91
2012-01-01 to 2012-06-30-5,549,208USD182

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-01-01 to 2013-06-30412,184USD181
2001-07-13 to 2013-06-304,810,678USD4371
2012-01-01 to 2012-06-30488,658USD182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-165,961USD91
2013-01-01 to 2013-06-30-342,167USD181
2001-07-13 to 2013-06-30-2,339,940USD4371
2012-04-01 to 2012-06-30-149,424USD91
2012-01-01 to 2012-06-30-232,488USD182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2013-01-01 to 2013-06-304,680,775USD181
2001-07-13 to 2013-06-3030,448,785USD4371
2012-01-01 to 2012-06-302,973,946USD182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-06-30100,718USD181
2001-07-13 to 2013-06-30258,471USD4371
2012-01-01 to 2012-06-3049,696USD182

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-06-30-297,554USD181
2001-07-13 to 2013-06-30607,632USD4371
2012-01-01 to 2012-06-30544,521USD182

Inspect the source

Entity
Protea Biosciences Group, Inc. / CIK 0001335103
Captured
SEC response SHA-256
6b487b6d6aa0a735e07855358b10c0014003743452cad5b8c8bf2155ac6c1078

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001335103.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))